Molecular Basis of Insulin Resistance
胰岛素抵抗的分子基础
基本信息
- 批准号:7991947
- 负责人:
- 金额:$ 6.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-03 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdverse effectsAgeAnimal ModelBlood PressureBlood VesselsBody WeightBody Weight decreasedCarbonCardiovascular DiseasesConsumptionDataDeveloping CountriesDevelopmentDietDietary InterventionDiseaseDyslipidemiasEnvironmentEpidemicEpigenetic ProcessExposure toFat-Restricted DietFatty acid glycerol estersFetal Growth RetardationFollow-Up StudiesFunctional disorderGLUT4 geneGene ExpressionGenesGeneticGenetic Predisposition to DiseaseGlucoseGuidelinesHealthHepaticHomeostasisHumanHyperglycemiaHypertensionIncidenceIndividualInsulinInsulin ResistanceLactationLesionLifeLinkLipidsLiverLow Birth Weight InfantMaintenanceMalnutritionMeasuresMediatingMetabolicMetabolic DiseasesMetabolic syndromeMetabolismMethylationModelingModificationMolecularMothersMusNeuraxisNon-Insulin-Dependent Diabetes MellitusNutrientObesityOrganPathologicPathologyPeripheralPeroxisome Proliferator-Activated ReceptorsPlaguePlayPredispositionPregnancyProcessRegulationRiskRisk FactorsRodentRoleSeveritiesSignal TransductionSkeletal MuscleSocietiesSupplementationTestingTissuesWeaningWeight GainWomanbaseblood glucose regulationcohortdisease transmissionfetalglucose toleranceglucose uptakeglucose-6-phosphataseimpaired glucose tolerancein uteroinsightinsulin sensitivityketogenic dietmalemouse modelnoveloffspringpregnantpreventprogramsresponsevascular endothelial dysfunction
项目摘要
The incidence of Type 2 diabetes mellitus (T2DM) and the Metabolic Syndrome has reached epidemic
proportions. Human and rodent studies provide strong support for a genetic predisposition to these
pathologies. The GLUT4+/- mouse model (G4+/-) represents an example of an `At Risk' individual as male
G4+/- mice develop insulin resistance, hypertension and T2DM with age. Despite genetic predisposition, it is
clear that other factors play an important role in disease transmission and incidence. Studies have shown that
alterations in nutrients during early life `program' increased susceptibility to metabolic disease and
hypertension in adult life. However, these studies provide limited insight into the epigenetic mechanisms
underlying these processes. Consumption of a western style, high fat (HF) diet during pregnancy has also
been linked to vascular dysfunction, dyslipidemia and hyperglycemia in adults. Modulation of hepatic substrate
utilization and insulin sensitivity is crucial for maintenance of whole body glucose homeostasis as it integrates
signals from the gut, peripheral tissue and central nervous system. This process is disrupted in diseases such
as TD2M and the Metabolic Syndrome. Several models with alterations in the intrauterine (IU) milieu display
pathologic alterations in genes of hepatic glucose and lipid utilization (including PPAR? and G6Pase) often
associated with T2DM. The central hypothesis of this proposal is that consumption of a high fat (HF)
diabetogenic diet during pregnancy and lactation `programs' offspring for increased susceptibility to Metabolic
Syndrome and T2DM. We propose that increased susceptibility to the development of Metabolic Syndrome is
mediated by altered methylation of genes that regulate glucose and lipid utilization in liver. We predict dietary
intervention by adding one carbon donors will prevent these epigenetic modifications. Strong preliminary data
suggests PPAR? may play a pivotal role in mediating these effects. The contribution of enviromental factors
(IU diet) and offspring genetics (hemizygous lesion in peripheral glucose uptake, G4+/-) to alterations in
hepatic gene expression and methylation related to the incidence of T2DM and Metabolic Syndrome will be
measured. Molecular mechanisms underlying the early life programming of these metabolic derangements will
be revealed. Additional studies are proposed to test the response of high fat IU offspring to diets that alter body
weight and metabolism including a high fat diabetogenic diet or a weight loss ketogenic diet during their adult
life. Results of these studies may yield new information for setting dietary guidelines for pregnant and lactating
women that may protect offspring from enhanced susceptibility to these metabolic diseases. Type 2 diabetes mellitus (T2DM) and the Metabolic Syndrome are modern day plagues of societies in
industrialized and developing nations alike. Studies have shown that alterations in nutrients during early life
`program' increased susceptibility to metabolic disease. However, these studies provide limited insight into the
potential epigenetic mechanisms underlying these processes. This proposal seeks to define the molecular
basis underlying the programming of Metabolic Syndrome and T2DM using normal mice and ones genetically
`at risk' for developing metabolic diseases. Results of these studies may yield new information for setting
guidelines for pregnant and lactating women that may protect offspring from enhanced susceptibility to these
metabolic diseases.
2 型糖尿病 (T2DM) 和代谢综合征的发病率已达到流行趋势
比例。人类和啮齿动物研究为这些疾病的遗传倾向提供了强有力的支持
病理学。 GLUT4+/- 小鼠模型 (G4+/-) 代表“处于危险中”的男性个体的一个例子
G4+/- 小鼠随着年龄的增长会出现胰岛素抵抗、高血压和 T2DM。尽管有遗传倾向,但
明确其他因素在疾病传播和发病中发挥着重要作用。研究表明
生命早期“计划”期间营养物质的改变增加了对代谢疾病的易感性
成人生活中的高血压。然而,这些研究对表观遗传机制的了解有限。
这些过程的基础。怀孕期间食用西式高脂肪 (HF) 饮食也会导致
与成人血管功能障碍、血脂异常和高血糖有关。肝底物的调节
利用率和胰岛素敏感性对于维持全身葡萄糖稳态至关重要,因为它整合
来自肠道、周围组织和中枢神经系统的信号。这个过程在疾病中被破坏,例如
如 TD2M 和代谢综合症。几种具有宫内 (IU) 环境显示变化的模型
肝脏葡萄糖和脂质利用基因(包括 PPAR? 和 G6Pase)经常发生病理改变
与 T2DM 相关。该提案的中心假设是摄入高脂肪(HF)
怀孕和哺乳期间的糖尿病饮食会增加后代对代谢的易感性
综合征和 T2DM。我们认为,代谢综合症的易感性增加是
由调节肝脏中葡萄糖和脂质利用的基因甲基化改变介导。我们预测饮食
通过添加一个碳供体进行干预将阻止这些表观遗传修饰。强有力的初步数据
建议PPAR?可能在调节这些影响中发挥关键作用。环境因素的贡献
(IU 饮食)和后代遗传学(外周葡萄糖摄取的半合子病变,G4+/-)对
与 T2DM 和代谢综合征发病相关的肝脏基因表达和甲基化将
测量。这些代谢紊乱的早期生命编程背后的分子机制将
被揭露。建议进行更多研究来测试高脂肪 IU 后代对改变身体的饮食的反应
体重和新陈代谢,包括成年期间的高脂肪糖尿病饮食或减肥生酮饮食
生活。这些研究的结果可能会为制定孕妇和哺乳期饮食指南提供新信息
女性可能会保护后代免受这些代谢疾病的易感性增加。 2 型糖尿病 (T2DM) 和代谢综合征是现代社会的瘟疫
工业化国家和发展中国家都一样。研究表明,生命早期营养物质的变化
“程序”增加了对代谢疾病的易感性。然而,这些研究对这一问题的了解有限
这些过程背后的潜在表观遗传机制。该提案旨在定义分子
使用正常小鼠和遗传小鼠进行代谢综合征和 T2DM 编程的基础
处于患代谢疾病的“风险”中。这些研究的结果可能会为设置提供新的信息
针对孕妇和哺乳期妇女的指南,可保护后代免受这些疾病的易感性增加
代谢性疾病。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
- DOI:10.2337/db10-0426
- 发表时间:2011-02
- 期刊:
- 影响因子:7.7
- 作者:Lee Y;Wang MY;Du XQ;Charron MJ;Unger RH
- 通讯作者:Unger RH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAUREEN J CHARRON其他文献
MAUREEN J CHARRON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAUREEN J CHARRON', 18)}}的其他基金
Impact of COVID-19 and Structural Racism on Maternal Mental Health and the Bronx MomBa Cohort
COVID-19 和结构性种族主义对孕产妇心理健康和布朗克斯 MomBa 群体的影响
- 批准号:
10393077 - 财政年份:2021
- 资助金额:
$ 6.88万 - 项目类别:
Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction
通过宫内生长受限进行儿童早期肥胖规划的分子基础
- 批准号:
10116433 - 财政年份:2018
- 资助金额:
$ 6.88万 - 项目类别:
Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction
通过宫内生长受限进行儿童早期肥胖规划的分子基础
- 批准号:
10359117 - 财政年份:2018
- 资助金额:
$ 6.88万 - 项目类别:
Altered Glucose and Lipid Metabolism in Obesity and CVD
肥胖和心血管疾病中葡萄糖和脂质代谢的改变
- 批准号:
6944754 - 财政年份:2003
- 资助金额:
$ 6.88万 - 项目类别:
Altered Glucose and Lipid Metabolism in Obesity and CVD
肥胖和心血管疾病中葡萄糖和脂质代谢的改变
- 批准号:
7263925 - 财政年份:2003
- 资助金额:
$ 6.88万 - 项目类别:
Altered Glucose and Lipid Metabolism in Obesity and CVD
肥胖和心血管疾病中葡萄糖和脂质代谢的改变
- 批准号:
6602637 - 财政年份:2003
- 资助金额:
$ 6.88万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 6.88万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 6.88万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 6.88万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 6.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 6.88万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 6.88万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 6.88万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 6.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 6.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 6.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)